Barrett's esophagus: Prevalence and its relationship with dyspeptic symptoms

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 5, 2004, Pages 535-540

  Toruner, Murat ^a   Soykan, Irfan ^a   Ensari, Arzu ^a   Kuzu, Isinsu ^a   Yurdaydin, Cihan ^a   Özden, Ali ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Barrett's esophagus; Dyspeptic symptoms

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DYSPEPSIA; ENDOSCOPY; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROSCOPY; HIATUS HERNIA; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTPATIENT; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL;

EID: 2442687805     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2003.03342.x     Document Type: Article

References (39)

1. Spechler SJ, Lee E, Ahnen D et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 2001; 283: 2331-8.
2. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119: 333-8.
3. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-9.
4. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1988; 83: 2049-53.
5. Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br. J. Cancer 1990; 62: 440-3.
6. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int. J. Epidemiol. 2000; 29: 645-54.
7. Spechler SJ. Barrett's esophagus. Semin. Gastroint. Dis. 1996; 7: 51.
8. Haggitt RC, Tryzelaar J, Ellis FH, Colcher H. Adenocarcinoma complicating columnar epithelial lined (Barrett's) esophagus. Am. J. Surg. Pathol. 1978; 70: 1-5.
9. Paraf F, Flejou JF, Pignon JP, Fekete F, Potet F. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Am. J. Surg. Pathol. 1995; 19: 183-91.
10. Winters C Jr, Spurling TJ, Chobanian SJ et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux. Gastroenterology 1987; 92: 118-24.
11. Eisen GM, Sandler RS, Murray S, Gottfried M. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am. J. Gastroenterol. 1997; 92: 27-31.
12. Lieberman D, Oehlke M, Helfand M. GORE consortium. Risk factors for Barrett's esophagus in community based practice. Am. J. Gastroenterol. 1997; 92: 1293-7.
13. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461-7.
14. Azuma N, Endo T, Arimura Y et al. Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan. J. Gastroenterol. 2000; 35: 583-92.
15. Hirato WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RKH. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999; 116: 277-85.
16. Chandrasoma PTR, Ma Y, Peters J, Demeester T. Histologic classification of patients based on mapping biopsies of the gastroesophageal junction. Am. J. Surg. Pathol. 2003; 27: 929-36.
17. Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of esophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-80.
18. Sharma P, McCallum RW, Lundell L. The geoprevalence of Barrett's esophagus. (Paper presented at the Sixth OESO World Congress; September 2000, Paris, France).
19. Yurdaydin C, Krastev Z, Bulajic M et al. Gastrointestinal tract cancer in Southeastern Europe: a multinational study with the participation of seven countries. Gut 2002; 51 (Suppl. III): A263.
20. Dincer D, Besisik F, Sahin E, Demir K. Intestinal metaplasia of the gastric cardia: a study form Turkey. Hepatogastroenterol. 2002; 49: 1153-6.
21. Gerson LB, Edson R, Lavori PW, Triadafilopoulos G. Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am. J. Gastroenterol. 2001; 96: 2005-12.
22. Voutilainen M, Farkkila M, Juhola M et al. Specialized columnar epithelium of the esophagogastric junction: prevalence and associations. Am. J. Gastroenterol. 1999; 94: 913-8.
23. Hirota WK, Loughney TM, Lazas DJ et al. The prevalence and demographics of specialized intestinal metaplasia at the esophagogastric junction in a cohort of 989 prospectively studied patients. Gastroenterology 1997; 112 (Suppl.): A149.
24. Padda S, Ramirez F. Accuracy in the diagnosis of SSBE: the role of endoscopie experience. Gastrointestinal Endosc. 2001; 54: 605-8.
25. Eloubeidi MA, Provenzale D. Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy. Am. J. Gastroenterol. 1999; 94: 937-43.
26. Cameron AJ. Barrett's esophagus: prevalence and size of hiatal hernia. Am. J. Gastroenterol. 1999; 94: 2054-9.
27. Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus. Dig. Dis. Sci. 2002; 47: 256-64.
28. Johnston MH, Hammond AS, Laskin WL et al. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am. J. Gastroenterol. 1996; 91: 1507-11.
29. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastroesophageal junction. Lancet 1994; 344: 1533-6.
30. Nandurkar S, Talley NJ, Martin CJ, Ng TH, Adams S. Short segment Barrett's esophagus: Prevalence, diagnosis and associations. Gut 1997; 40: 710-5.
31. Pereira AD, Suspiro A, Chaves P et al. Short segments of Barrett's epithelium and intestinal metaplasia in normal appearing esophagogastric junctions: The same or two different entities? Gut 1998; 42: 659-62.
32. Johnston MH, Hammond AS, Laskin W, Jones DM. The prevalence and characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am. J. Gastroenterol. 1996; 91: 1507-11.
33. Goldblum JR, Vicari JJ, Falk GW et al. Inflammation and intestinal metaplasia of gastric cardia: The role of gastroesophageal reflux and H. pylori infection. Gastroenterology 1998; 114: 633-9.
34. Abbas Z, Hussainy AS, Ibrahim F, Jafri SM, Shaikh H, Khan AH. Barrett's esophagus and Helicobacter pylori. J. Gastroenterol. Hepatol. 1995; 10: 331-3.
35. Loffeld RJLF, Ten Tije BJ, Arends JW. Prevalence and significance of Helicobacter pylori in patients with Barrett's esophagus. Am. J. Gastroenterol. 1992; 87: 1598-600.
36. Newton M, Bryan R, Burnham WR, Kamm MA. Evaluation of Helicobacter pylori in reflux esophagitis and Barrett's esophagus. Gut 1997; 40: 9-13.
37. Hackelsberger A, Günther T, Schutze V et al. Intestinal metaplasia at the gastroesophageal junction: Helicobacter pylori gastritis or gastroesophageal reflux disease? Gut 1998; 43: 17-21.
38. Oberg S, Peters JH, Nigro JJ et al. Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease. Arch. Surg. 1999; 134: 722-6.
39. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988; 48: 3554-60.